Position in OGN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$284,710
-$131,673 QoQ
Shares Held
47,531
+70.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IMC-Chicago, LLC holds $56,648,218 across 9 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,449 | $30,524,296 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
128,157 | $7,384,406 | |
| 3 | BIIB |
Biogen Inc.
|
20,649 | $4,461,422 | |
| 4 | PFE |
Pfizer Inc
|
173,689 | $4,182,431 | |
| 5 | AMGN |
Amgen Inc
|
8,927 | $3,232,645 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,216 | $2,933,109 | |
| 7 | NVS |
Novartis AG
|
9,740 | $1,526,452 | |
| 8 | AZN |
Astrazeneca PLC
|
7,754 | $1,470,313 |
All Filings in OGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $284,710 | 47,531 | Shares | Sole | 2026-05-05 | |
| 2025-03-31 | $416,383 | 27,964 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,300,934 | 87,194 | Shares | Sole | 2025-01-27 | |
| 2024-03-31 | $243,460 | 12,950 | Shares | Sole | 2024-04-12 | |
| No filing history on record for this holder in this stock. | ||||||